We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Information about how the MHRA regulates medical devices in Northern Ireland and what legislation applies to manufacturers and suppliers.
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
Find out which COVID-19 test products have been approved.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
The MHRA's initial plans on an Early Access service, which will be developed further throughout 2025.
Information about medical devices that the public can buy for personal use and how we make sure they are safe and effective.
How to conform with the legal requirements for placing medical devices on the market.
A summary of the types of scientific advice available at the MHRA, the process for getting advice and the fees involved.
How to apply for a clinical trial from 28 April 2026, including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The process for applicants applying for a paediatric investigation plan (PIP) modification or waiver.
Fees payable to the MHRA from 2025.
Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
Consumer advice and details of how to report problems with e-cigarettes with guidance on how to place an e-cigarette on the market in Great Britain and Northern Ireland, including the notification scheme.
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.
Guidance on labelling for medicinal products used in clinical trials.
Information on when software applications (apps) are considered to be a medical device and how they are regulated.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).